Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Robert G Price"'
Publikováno v:
Biomarker Insights, Vol 17 (2022)
Environmental and occupational exposure to heavy metals and metalloids is a major global health risk. The kidney is often a site of early damage. Nephrotoxicity is both a major consequence of heavy metal exposure and potentially an early warning of g
Externí odkaz:
https://doaj.org/article/f37e60add4fd497d98b8e1e4cfb3d4e0
Autor:
Ian Pavord, Robert Chan, Nicola Brown, Peter Howarth, Martyn Gilson, Robert G. Price, Jorge Maspero
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
Objectives Long-term safety monitoring of mepolizumab is necessary to support real-world use for the treatment of severe asthma. This Long-Term Access Program assessed the safety and benefit:risk of mepolizumab in pediatric, adolescent, and adult pat
Externí odkaz:
https://doaj.org/article/bd0898e3f87142f18fa40e8716ed1f0d
Autor:
Erika Bíró, István Szegedi, Csongor Kiss, Anna V. Oláh, Mark Dockrell, Robert G. Price, Tamás Szabó
Publikováno v:
BMC Pediatrics, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background The 1-year cumulative incidence of AKI reportedly is high (52%) in pediatric neoplastic disorders. About half of these events occur within 2 weeks. However, subclinical AKI episodes may remain unrecognized by the conventional crea
Externí odkaz:
https://doaj.org/article/449fca4ed6554d3baf9a765491538206
Autor:
Zsolt Ráduly, András Szabó, Miklós Mézes, Ildikó Balatoni, Robert G. Price, Mark E. Dockrell, István Pócsi, László Csernoch
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
The gradual spread of Aspergilli worldwide is adding to the global shortage of food and is affecting its safe consumption. Aspergillus-derived mycotoxins, including aflatoxins and ochratoxin A, and fumonisins (members of the fusariotoxin group) can c
Externí odkaz:
https://doaj.org/article/32fa9471e8114c1eb0ab715f3a5e71a5
Autor:
Ian Pavord, Frances Gardiner, Liam G. Heaney, Christian Domingo, Robert G. Price, Alison Pullan, John Oppenheimer, Guy Brusselle, Hiroyuki Nagase, Geoffrey Chupp, Emilio Pizzichini, David Bañas-Conejero, Peter Howarth
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionClinical remission as a multicomponent treatment goal in severe asthma is being explored in clinical practice. This post hoc analysis used data from the REDES study to assess the proportion of patients with severe eosinophilic asthma achi
Externí odkaz:
https://doaj.org/article/6a2297173f974771a34c24c5b9b4fa5c
Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma
Autor:
Stephanie Korn, Peter Howarth, Steven G. Smith, Robert G. Price, Steven W. Yancey, Charlene M. Prazma, Elisabeth H. Bel
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Long-term use of oral corticosteroids (OCS) is associated with a risk of adverse events and comorbidities. As such, a goal in assessing the efficacy of biologics in severe asthma is often to monitor reduction in OCS usage. Importa
Externí odkaz:
https://doaj.org/article/52dc326293d44a9c9adb6b89c41f95c9
Autor:
Mark C. Liu, Bradley Chipps, Xavier Munoz, Gilles Devouassoux, Miguel Bergna, Steven G. Smith, Robert G. Price, Dmitry V. Galkin, Jay Azmi, Dalal Mouneimne, Frank C. Albers, Kenneth R. Chapman
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background The OSMO study assessed the efficacy of switching to mepolizumab in patients with severe eosinophilic asthma that was uncontrolled whilst receiving omalizumab. The objective of this analysis was to assess the proportion of patient
Externí odkaz:
https://doaj.org/article/b4e2e90b44bf489cab4a132a23dc52f2
Autor:
Ian D. Pavord, Roland Buhl, Monica Kraft, Charlene M. Prazma, Robert G. Price, Peter H. Howarth, Steven W. Yancey
Publikováno v:
ERJ Open Research, Vol 8, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/76317a21f29a45408905b93037f416d6
Autor:
Laura Pini, Cristiano Caruso, Stefania Colantuono, Diego Bagnasco, Aoife Maxwell, Robert G. Price, Peter Howarth, Giorgio Walter Canonica, Italian investigators of REALITI‐A
Publikováno v:
Clinical and Translational Allergy, Vol 11, Iss 8, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/4bcdf93e200c41dc8e00af5c3dde0e33
Autor:
Charles Pilette, Giorgio Walter Canonica, Rekha Chaudhuri, Geoffrey Chupp, F. Eun-Hyung Lee, Jason Kihyuk Lee, Carlos Almonacid, Tobias Welte, Rafael Alfonso-Cristancho, Rupert W. Jakes, Aoife Maxwell, Robert G. Price, Peter Howarth
Background:\ud Patients with severe asthma may require maintenance oral corticosteroids (mOCS) for disease control as well as systemic corticosteroid (SCS) bursts for clinically significant exacerbations (CSEs); however, mOCS and SCS use are associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb94848c12d17d653e950a08c4a2fb19
https://eprints.gla.ac.uk/274767/1/274767.pdf
https://eprints.gla.ac.uk/274767/1/274767.pdf
